|
It was reported that during a percutaneous transluminal angioplasty (pta) of the moderate to severely calcified left distal superficial femoral(sfa)/proximal popliteal(prox.Pop.A) arteries, the advance 35 lp low profile balloon catheter ruptured longitudinally.The complaint device was inserted by traditional up and over fashion, and advanced to the left distal sfa/prox.Pop.A where a stent had been previously placed.This was a post dilatation procedure.The advance 35 lp low profile balloon catheter was inflated to rated burst pressure(rbp ) of 14 atmospheres (atm)at which point, it ruptured.The physician was able to remove the complaint device without leaving a portion in the patient's anatomy.The procedure was completed successfully with the complaint device since the angioplasty procedure had been completed at the time of the device rupture.A section of the device did not remain inside the patient¿s body.The patient did not require any additional procedures due to this occurrence.According to the initial reporter, the patient did not experience any adverse effects due to this occurrence.
|
|
Investigation ¿ evaluation.A review of the complaint history, device history record, documentation, drawing, instructions for use, quality control, and specifications of the device was conducted during the investigation.The complaint device was not returned; therefore, no physical examinations could be performed.However, a document based investigation evaluation was performed.A review of the device history record shows 5 nonconforming events which could contribute to this failure mode; however, due to the individual nature of the product manufacturing and 100% verification of various defects including foreign matter, leak testing, inspection of balloon surface and catheter surface in final quality control prior to shipping, there is no indication that there is nonconforming product in the field.It should be noted there were no other reported complaints for this lot number.Based on the information provided, no product returned and the results of our investigation, a definitive root cause could not be determined.Measures are being conducted to address this failure mode.We will continue to monitor for similar complaints.Per the quality engineering risk assessment, no further action is required.This report is required by the fda under 21 cfr part 803.This report is based on unconfirmed information submitted by others.Neither the submission of this report nor any statement made in it is intended to be an admission that any cook device is defective or malfunctioned; that a death or serious injury occurred; or that any cook device caused or contributed to; or is likely to cause or contribute to a death or serious injury if a malfunction occurred.
|